Multiple Gestation Study

Completed

Conditions studied: Trisomy 13, Trisomy 18, Trisomy 21, Sex Chromosome Abnormalities

In brief

The objectives of the clinical study are to demonstrate the accuracy of our new NATUS diagnostic method to determine the genetic health of the developing fetuses in a multiple gestation pregnancy from a maternal blood sample. The long term goal of this study will be the development of a method of minimally invasive prenatal diagnosis that has a higher sensitivity and lower false positive rate in the intended population (e.g. multiple gestation pregnancies) than any currently available screening tests. This will result in fewer unnecessary amniocenteses and CVS procedures, which are associated with a risk of miscarriage.

Key facts

Study ID: NCT02278536
Run by: Natera, Inc.
People needed: 354
Starts: 2013-03-01
Expected to finish: 2019-03-01
Last updated by the study team: 2019-08-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

Age 18 or older at enrollment
Clinically confirmed multiple gestation pregnancy
Gestational age between ≥ 9 weeks, 0 days and ≤26 weeks 0 days by best obstetrical estimate
Able to provide informed consent

You may not qualify if…

Women carrying singleton pregnancy
Surrogate or egg donor used

Where it is running

Natera, Inc. — San Carlos, California, United States
San Diego Perinatal Center — San Diego, California, United States
Carnegie Hill Imaging for Women — New York, New York, United States
Lyndhurst Clinical Research — Winston-Salem, North Carolina, United States
Office of Dr. Robert Carpenter — Houston, Texas, United States
Houston Perinatal Associates — Houston, Texas, United States
Bangalore Fetal Medicine Centre — Bangalore, India
Fetal Medicine & Gynaecology Centre — Petaling Jaya, Selangor, Malaysia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.